Home Newsfeeds Immuron Submits IND Application To FDA For Travelan

Immuron Submits IND Application To FDA For Travelan

Investigational New Drug (IND) application submitted to the U.S. Food and Drug administration (FDA) Plans in place to initiate a Human clinical trial in 60 healthy volunteers in the USA Clinical Trial to examine a

byBenzinga Newsdesk

December 5, 2022

1 minute read

Investigational New Drug (IND) application submitted to the U.S. Food and Drug administration (FDA)
Plans in place to initiate a Human clinical trial in 60 healthy volunteers in the USA
Clinical Trial to examine a dosing regimen for Travelan more suited for use by the US military
- Infectious diarrhea is the most common illness reported by travelers

General
News

What’s Going On With Grocery Wholesaler United Natural Foods Stock Wednesday?

By Shivani Kumaresan

June 5, 9:49 AM

United Natural Foods shares rise after Q3 FY24 results. Despite a slight sales decline to $7.498 billion, the gross margin improved to 13.6%. Adjusted EPS of $0.10 surpassed the $0.03 estimate. UNFI forecasts FY24 sales of $30.5-$31 billion and adjusted EPS of $(0.20)-$0.20.

UNFI